The city of Newport Beach, California, currently has 4 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Recruiting
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.
Gender:
ALL
Ages:
55 years and above
Trial Updated:
10/18/2024
Locations: Clinical Site, Newport Beach, California
Conditions: Psychosis Associated With Alzheimer's Disease
Study of AV-1959D, an Amyloid Beta Vaccine
Recruiting
Phase 1 clinical trial of AV-1959 amyloid-β vaccine for Alzheimer's disease (AD).
Gender:
ALL
Ages:
Between 60 years and 85 years
Trial Updated:
09/30/2024
Locations: Hoag Memorial Hospital, Newport Beach, California
Conditions: Alzheimer Disease
A Study of AMDX-2011P in Participants With Alzheimer's Disease
Recruiting
The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer's Disease (AD).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2024
Locations: Eye Research Foundation, Newport Beach, California
Conditions: Alzheimer Disease
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Recruiting
This is a research study to evaluate the safety of an investigational autologous cell product obtained from participant's own adipose tissue as a possible treatment for Alzheimer disease.
Gender:
All
Ages:
Between 45 years and 80 years
Trial Updated:
02/08/2024
Locations: Hoag Memorial Hospital Presbyterian, Newport Beach, California
Conditions: Alzheimer Disease